Table 3.

(a) Segmental analysis of CMR-FT comparing LV segments that do not get LGE (inferoseptal and anteroseptal) with segments shown to have LGE (inferolateral and anterolateral) in DMD subjects; (b) segmental analysis of STE comparing LV segments that do not get LGE (inferoseptal and anteroseptal) with segments shown to have LGE (inferolateral and anterolateral) in DMD subjects

(a)
CMR-FT	Group	Inferoseptal	Anterolateral	p value	Anteroseptal	Anterolateral	p value
Segmental circumferential strain	LGE− (N = 11) LGE+ (N = 13)	−21.13 ± 8.82 −19.23 ± 1.84	−16.47 ± 7.07 −13.00 ± 1.34	0.08 0.004	−23.34 ± 10.08 −24.55 ± 8.73	−16.47 ± 7.07 −13.00 ± 4.84	0.06 0.002
	Group	Inferoseptal	Inferolateral	p value	Anteroseptal	Inferolateral	p value
Segmental circumferential strain	LGE− (N = 11) LGE+ (N = 13)	−21.13 ± 8.82 −19.23 ± 6.65	−18.23 ± 8.32 −15.49 ± 8.99	0.28 0.10	−23.34 ± 10.08 −24.55 ± 8.73	−18.23 ± 8.32 −15.49 ± 8.99	0.03 0.003
(b)
STE	Group	Inferoseptal	Anterolateral	p value	Anteroseptal	Anterolateral	p value
Segmental circumferential strain	LGE− (N = 11) LGE+ (N = 13)	−21.32 ± 6.27 −17.78 ± 7.62	−21.14 ± 5.15 −16.41 ± 7.58	0.95 0.55	−22.30 ± 6.78 −21.20 ± 6.94	−21.14 ± 5.15 −16.41 ± 7.58	0.63 0.023
	Group	Inferoseptal	Inferolateral	p value	Anteroseptal	Inferolateral	p value
Segmental circumferential strain	LGE− (N = 11) LGE+ (N = 13)	−21.32 ± 6.27 −17.78 ± 7.62	−21.96 ± 4.94 −18.68 ± 7.96	0.81 0.71	−22.30 ± 6.78 −21.20 ± 6.94	−21.96 ± 4.94 −18.68 ± 7.96	0.90 0.10

Data reported as mean ± SD